发明名称 |
COMBINATION THERAPY WITH THIOCOLCHICINE DERIVATIVES |
摘要 |
The present invention provides combination therapy methods of treating a proliferative disease (such as cancer) comprising administering to an individual an effective amount of a colchicine or thiocolchicine dimer and an anti-VEGF antibody. The method may further comprise administering an effective amount of a taxane. The colchicine or thiocolchicine dimer and the taxane (such as paclitaxel) may be present in the form of nanoparticles, such as nanoparticles comprising the drug and a carrier protein such as albumin. |
申请公布号 |
US2017105951(A1) |
申请公布日期 |
2017.04.20 |
申请号 |
US201615217763 |
申请日期 |
2016.07.22 |
申请人 |
Abraxis BioScience, LLC |
发明人 |
DESAI Neil P.;TRIEU Vuong |
分类号 |
A61K31/165;A61K9/00;A61K9/51;A61K39/395;A61K31/337 |
主分类号 |
A61K31/165 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a proliferative disease in an individual comprising administering to the individual:
a) an effective amount of a composition comprising a colchicine or thiocolchicine dimer, and b) an effective amount of anti-VEGF antibody. |
地址 |
Los Angeles CA US |